Senior insider sale
See Remarks at NEUMORA THERAPEUTICS, INC. — senior position signals high conviction
$5.1K
1.44K shares
What this filing means
MILLIGAN MICHAEL LEE plans to sell 1.44K shares of NEUMORA THERAPEUTICS, INC. valued at approximately $5.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001964306-26-000109
Officer· See Remarks
Since Feb 2026
1.44K
Shares to sell
$5.1K
Approx. market value
1.44K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
2/14/2026
1.44KTotal acquired1.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 1.44K | — |
| Total | 1.44K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.44K
Market value
$5.1K
2/17/2026
Total
Units
1.44K
Value
$5.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/17/2026 | 1.44K | $5.1K | NASDAQ | Planned |
| Total | 1.44K | $5.1K | ||